Topics
ketamineChemical substance
For decades clinicians and scientists have been searching for an alternative to rapidly treat patients with TRD. This dilemma may be partly resolved for some patients. A new use for an old drug, ketamine, promises to be effective for treatment of TRD. This new role for ketamine will be explored with particular emphasis on whether it is effective, and if so, how durable its benefits are
The SARS-CoV-2 coronavirus epidemic has led to an increase in the number of people with depression. ...
Many recent studies have demonstrated the ability of ketamine, an NMDA receptor antagonist, to produ...
Repurposing ketamine in the therapy of depression could well represent a breakthrough in understandi...
For decades clinicians and scientists have been searching for an alternative to rapidly treat patien...
Background: Treatment-resistant depression (TRD) is a relatively common condition, challenging the c...
Over the last few years, ketamine has been studied as a possible treatment option for Major Depressi...
Millions of people around the world suffer from Major Depressive Disorder, and many of these people ...
An increasing amount of research suggests Ketamine in subanaesthetic doses to be an effective antide...
Ketamine, via intravenous infusions, has emerged as a novel therapy for treatment-resistant depressi...
At least 10-20\% of the patients suffering from depression meet criteria for treatment-resistant dep...
Over the last two decades, the dissociative anaesthetic agent ketamine, an uncompetitive N-Methyl-D-...
Ketamine has rapid yet often transient antidepressant effects in patients with treatment-resistant d...
Treatment-resistant depression is a pleomorphic phenomenon occurring in 30% of patients with depress...
Major depressive disorder (MDD) is a recurrent, incapacitating psychiatric illness which will be the...
Background: Depression is one of the most common mental disorders. Currently used antidepressants, a...
The SARS-CoV-2 coronavirus epidemic has led to an increase in the number of people with depression. ...
Many recent studies have demonstrated the ability of ketamine, an NMDA receptor antagonist, to produ...
Repurposing ketamine in the therapy of depression could well represent a breakthrough in understandi...
For decades clinicians and scientists have been searching for an alternative to rapidly treat patien...
Background: Treatment-resistant depression (TRD) is a relatively common condition, challenging the c...
Over the last few years, ketamine has been studied as a possible treatment option for Major Depressi...
Millions of people around the world suffer from Major Depressive Disorder, and many of these people ...
An increasing amount of research suggests Ketamine in subanaesthetic doses to be an effective antide...
Ketamine, via intravenous infusions, has emerged as a novel therapy for treatment-resistant depressi...
At least 10-20\% of the patients suffering from depression meet criteria for treatment-resistant dep...
Over the last two decades, the dissociative anaesthetic agent ketamine, an uncompetitive N-Methyl-D-...
Ketamine has rapid yet often transient antidepressant effects in patients with treatment-resistant d...
Treatment-resistant depression is a pleomorphic phenomenon occurring in 30% of patients with depress...
Major depressive disorder (MDD) is a recurrent, incapacitating psychiatric illness which will be the...
Background: Depression is one of the most common mental disorders. Currently used antidepressants, a...
The SARS-CoV-2 coronavirus epidemic has led to an increase in the number of people with depression. ...
Many recent studies have demonstrated the ability of ketamine, an NMDA receptor antagonist, to produ...
Repurposing ketamine in the therapy of depression could well represent a breakthrough in understandi...
Add to ORKG